Deron Herr
Affiliations: | 2004-2011 | Scripps Research Institute, La Jolla, La Jolla, CA, United States |
Google:
"Deron Herr"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Alexander SPH, Christopoulos A, Davenport AP, et al. (2023) The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors. British Journal of Pharmacology. S23-S144 |
| Xiang P, Chew WS, Seow WL, et al. (2021) The S1P receptor regulates blood-brain barrier integrity and leukocyte extravasation with implications for neurodegenerative disease. Neurochemistry International. 105018 |
| Chua XY, Ho LTY, Xiang P, et al. (2020) Preclinical and Clinical Evidence for the Involvement of Sphingosine 1-Phosphate Signaling in the Pathophysiology of Vascular Cognitive Impairment. Neuromolecular Medicine |
| Wang W, Shanmugam MK, Xiang P, et al. (2020) Sphingosine 1-Phosphate Receptor 2 Induces Otoprotective Responses to Cisplatin Treatment. Cancers. 12 |
| Wang W, Xiang P, Chew WS, et al. (2019) Activation of sphingosine 1-phosphate receptor 2 attenuates chemotherapy-induced neuropathy. The Journal of Biological Chemistry |
| Herr DR, Chew WS, Satish RL, et al. (2019) Pleotropic Roles of Autotaxin in the Nervous System Present Opportunities for the Development of Novel Therapeutics for Neurological Diseases. Molecular Neurobiology |
| Srikanth M, Chew WS, Hind T, et al. (2018) Lysophosphatidic acid and its receptor LPA mediate carrageenan induced inflammatory pain in mice. European Journal of Pharmacology |
| Thirunavukkarasan M, Wang C, Rao A, et al. (2017) Short-chain fatty acid receptors inhibit invasive phenotypes in breast cancer cells. Plos One. 12: e0186334 |
| Patmanathan SN, Wang W, Yap LF, et al. (2017) Mechanisms of sphingosine 1-phosphate receptor signalling in cancer. Cellular Signalling |
| Chew WS, Wang W, Herr DR. (2016) To fingolimod and beyond: the rich pipeline of drug candidates that target S1P signaling. Pharmacological Research |